查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974164

超音波市场：按产品、组件、便携性、显示类型、应用和最终用户划分－全球预测，2026-2032年

Ultrasound Market by Product, Component, Portability, Display Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，超音波市场价值将达到 95.1 亿美元，到 2026 年将成长到 100.1 亿美元，到 2032 年将达到 139.4 亿美元，复合年增长率为 5.61%。

主要市场统计数据
基准年 2025 95.1亿美元
预计年份：2026年 100.1亿美元
预测年份：2032年 139.4亿美元
复合年增长率 (%) 5.61%

简要概述不断发展的超音波环境：技术融合、不断变化的临床需求以及在医疗保健服务中的战略意义。

超音波系统正经历着根本性的变革，其驱动力来自技术创新、临床工作流程的转变以及相关人员期望的不断变化。影像物理学的进步、软体驱动的影像增强技术以及人工智慧（AI）的发展，正在重新定义临床医生对超音波作为诊断和治疗手段的期望。同时，对照护现场诊断日益增长的需求、对经济高效诊疗路径的重视以及服务向传统医院环境之外的转移，正在重塑部署模式和采购重点。

人工智慧、小型化和不断发展的经营模式正在改写整个医疗保健领域超音波的应用和临床整合规则。

超音波诊断领域正经历快速发展和颠覆性的变革，多种转型趋势正在汇聚，改变影像和治疗的实施方式。首先，人工智慧和先进讯号处理技术的融合正从试点研究逐步走向临床工作流程的整合，实现了即时影像增强、自动测量和决策支援。这不仅降低了操作者差异，也使得非专业人员能够广泛应用超音波诊断技术。这一趋势推动了对不仅精准，而且能够与电子健康记录（EHR）和远端医疗平台无缝整合的系统的需求。

评估 2025 年美国关税变化将如何重塑超音波相关人员。

2025年，美国新的关税趋势对超音波设备製造商和医疗服务提供者的供应链经济和采购决策构成了重大限制。关键零件、子系统和成品关税的增加导致成本上升，即时造成价格压力，影响采购週期、资本支出核准和总拥有成本（TCO）的计算。对于拥有复杂全球供应链的产品以及依赖国内不易取得的专用零件的产品而言，这种压力尤其严重。

详细的細項分析揭示了产品、组件、便携性、显示、应用和最终用户方面的差异如何影响部署和商业化策略。

市场区隔有助于明确产品开发、商业化策略和临床应用。从产品层面来看，市场可分为诊断超音波系统和治疗超音波设备。诊断超音波系统可细分为二维超音波、三维/四维超音波和多普勒超音波，而治疗超音波设备则包括体外震波碎石术（ESWL）、高强度聚焦超音波（HIFU）和技术超音波。这种产品层面的区分凸显了不同的技术重点。诊断系统强调影像保真度、工作流程整合和人体工学，而治疗平台则优先考虑能量传递的精确性、标靶准确性和安全通讯协定。

美洲、欧洲、中东和非洲以及亚太地区的区域差异如何影响超音波技术的采用、监管和商业化策略？

区域趋势在技术采纳、监管管道和商业策略制定中发挥着至关重要的作用。在美洲，需求主要由以下因素驱动：追求高性能诊断能力的先进医院系统、照护现场超音波的广泛应用，以及人们对降低手术创伤性的治疗方式日益增长的兴趣。该地区也大力投资数位医疗整合，医保报销环境也越来越认可影像主导治疗管道的价值。

竞争行为和企业策略揭示了研发深度、软体生态系统和服务模式为何是领先超音波製造商之间决定性的差异化因素。

超音波领域的主要企业正同时关注多个策略要素：持续增加对探头技术和影像处理的研发投入，拓展软体和云端服务，以及采用以服务合约和软体订阅为核心的商业模式，以实现持续的收入成长。与学术机构和临床网路的合作也日益普遍，旨在获取真实世界的临床证据，以支持人工智慧演算法的独立检验、多中心性能数据，并与监管核准和支付方合作。

产业领导者应采取的实际策略重点和实施步骤，以将技术进步和政策转变转化为可持续的竞争优势。

产业领导者必须果断迅速采取行动，将结构性趋势转化为永续的优势。首先，应优先投资于人工智慧和内建软体，以切实提高诊断准确性和工作流程效率，并将演算法进步与严格的临床检验和透明的性能指标相结合，从而确保临床医生的信心并获得监管部门的核准。其次，应重组供应链以提高柔软性：对二级供应商进行认证，扩大区域製造和组装能力，并设计允许组件互换而无需进行重大重新设计的产品架构。

为了检验临床技术和商业性结论，我们采用了严格的混合方法研究方法，结合了二手证据、一手专家访谈和三角验证。

本分析的调查方法结合了定性和定量方法，以确保获得平衡且基于证据的观点。研究使用了二手资料，包括同行评审的临床文献、监管指导文件以及医疗设备製造商提供的公开信息，以此建立关于技术能力、安全标准和近期核准情况的客观基础。此外，研究还对临床医生、生物医学工程师、采购经理和行业高管进行了结构化的访谈，以收集关于推广应用障碍、工作流程影响和采购行为的实际见解。

融合检验的人工智慧、敏捷的供应链和整合服务模式：策略洞察支撑着它们为何定义超音波诊断领域的未来领导地位。

总之，超音波正从一项成熟的影像技术转型为集诊断、治疗和数位健康于一体的动态平台。人工智慧、改进的探头设计以及可携式外形规格等技术进步正在拓展其临床应用场景，并催生出结合软体、服务和以结果为导向的合约的新型经营模式。 2025年的关税调整和地缘政治发展正在加速关于供应链韧性、製造地和采购标准的讨论，并着重于风险缓解和生命週期价值。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：超音波市场：依产品划分

  • 诊断超音波系统
    • 二维超音波
    • 3D和4D超音波
    • 多普勒超音波
  • 治疗性超音波设备
    • 体外震波碎石术（ESWL）
    • 高强度聚焦超音波（HIFU）
    • 技术超音波

第九章：超音波市场：依组件划分

  • 探测
  • 工作站

第十章：超音波市场：可携式

  • 推车底座
  • 可携式和手持式

第十一章：超音波市场：依显示类型划分

  • 黑白超音波设备
  • 彩色超音波设备

第十二章超音波市场：依应用领域划分

  • 介入性手术
    • 麻醉和疼痛管理
    • 切片检查和引流
  • 医学诊断
    • 腹部影像
    • 乳腺影像
    • 心臟病学
    • 胃肠病学
    • 肌肉骨骼影像
    • 妇产科
    • 肿瘤学
    • 眼科
    • 泌尿系统
  • 研究与开发
  • 兽医学

第十三章：超音波市场：依最终用户划分

  • 门诊部
  • 医院
  • 妇产科中心
  • 研究所

第十四章：超音波市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：超音波市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：超音波市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国超音波市场

第十八章：中国超音波市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ALPINION Medical Systems Co., Ltd.
  • Analogic Corporation
  • B. Braun SE
  • Bioevopeak Co., Ltd.
  • Butterfly Network, Inc.
  • Canon Medical Systems Corporation
  • Cephasonics Ultrasound by White Eagle Sonic Technologies, Inc.
  • CIVCO Medical Solutions
  • CS Medical LLC
  • Echonous Inc.
  • Edan Instruments, Inc.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic Inc.
  • Konica Minolta Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shantou Institute of Ultrasonic Instruments Co., Ltd（SIUI）
  • Shimadzu Corporation
  • Siemens Healthcare Private Limited
  • SonoScape Medical Corp.
  • SternMed GmbH
  • Stryker Corporation
  • Telemed Medical Systems srl
  • WuHan Youkey Bio-Medical Electronics Co., Ltd.
Product Code: MRR-5D340F4413C5

The Ultrasound Market was valued at USD 9.51 billion in 2025 and is projected to grow to USD 10.01 billion in 2026, with a CAGR of 5.61%, reaching USD 13.94 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.51 billion
Estimated Year [2026] USD 10.01 billion
Forecast Year [2032] USD 13.94 billion
CAGR (%) 5.61%

A concise orientation to the evolving ultrasound landscape explaining technological convergence, clinical demand shifts, and strategic implications for care delivery

The ultrasound ecosystem is undergoing a fundamental transformation driven by converging technological innovations, shifting clinical workflows, and evolving stakeholder expectations. Advances in imaging physics, software-driven image enhancement, and artificial intelligence are redefining what clinicians expect from ultrasound as a diagnostic and therapeutic modality. At the same time, rising demand for point-of-care diagnostics, greater emphasis on cost-effective care pathways, and the migration of services outside traditional hospital settings are reshaping adoption patterns and procurement priorities.

This introduction synthesizes the forces that are driving new use cases and placing ultrasound at the center of non-invasive, real-time clinical decision-making. As clinicians push for earlier detection, shorter procedure times, and safer interventional guidance, the role of ultrasound is expanding beyond conventional imaging into therapeutic applications and integrated care platforms. The migration from fixed imaging suites to handheld and cart-based systems exemplifies how portability and immediate access are redefining clinical workflows across specialties.

Moreover, the interplay between hardware innovation and software ecosystems is creating a market where device performance, clinical validation, and software interoperability are equally important. Consequently, stakeholders must evaluate product roadmaps not only for transducer and console improvements but also for data management, cybersecurity, and AI-enabled clinical decision support. This framing sets the stage for deeper analysis of the structural shifts, policy impacts, segmentation dynamics, regional differences, and competitive behaviors explored in the subsequent sections.

How AI, miniaturization, and shifting commercial models are rewriting the rules of ultrasound adoption and clinical integration across care settings

The landscape of ultrasound is shifting in ways that are both evolutionary and disruptive, with several transformative trends converging to change how imaging and therapy are delivered. First, the integration of artificial intelligence and advanced signal processing has moved from pilot studies to embedded clinical workflows, enabling real-time image enhancement, automated measurements, and decision-support that reduce operator variability and unlock broader use by non-specialists. This drives demand for systems that are not only accurate but also seamlessly integrated with electronic health records and telehealth platforms.

Concurrently, miniaturization and improvements in probe design have accelerated the transition from large cart-based consoles to lightweight portable and handheld devices, expanding access in emergency care, outpatient clinics, and remote settings. These shifts are complemented by the growing clinical acceptance of therapeutic ultrasound modalities such as high-intensity focused ultrasound and shockwave therapies, which are increasingly viewed as non-invasive alternatives that can reduce hospital stays and improve patient throughput.

In addition, commercial models are transforming: subscription-based software, image-as-a-service platforms, and outcome-based procurement are altering purchasing decisions and long-term vendor relationships. Regulatory frameworks and reimbursement pathways are adapting to accommodate AI-enabled tools and software updates, which in turn alters time-to-market strategies and ongoing compliance obligations. Together, these trends are not only altering product development priorities but also creating new competitive battlegrounds where data, software ecosystems, and service capabilities matter as much as transducer performance.

Assessment of how U.S. tariff shifts in 2025 are reshaping procurement, supply chain resilience, and long-term manufacturing decisions for ultrasound stakeholders

In 2025, new tariff dynamics in the United States have introduced a material constraint on supply chain economics and procurement decision-making for ultrasound manufacturers and healthcare providers. Tariff-driven cost increases on critical components, subsystems, or finished devices create immediate pricing pressures that reverberate across procurement cycles, capital expenditure approvals, and total cost of ownership calculations. These pressures are most acute for products with complex global supply chains and dependence on specialized components that are not readily sourced domestically.

As a result, organizations are responding with a combination of tactical and strategic measures that mitigate exposure while preserving access to essential technologies. In the near term, manufacturers are accelerating efforts to redesign products for component flexibility, qualify secondary suppliers in tariff-neutral jurisdictions, and absorb short-term costs through pricing strategies designed to maintain market competitiveness. At the same time, procurement teams within provider organizations are recalibrating tender specifications to include supply chain resilience criteria, extended warranty terms, and service-level guarantees that hedge against component-related disruptions.

Over a medium-term horizon, tariffs are prompting broader reconsideration of manufacturing footprints and supplier relationships. Some companies are increasing local assembly or final-stage manufacturing to reduce border-related charges, while others pursue nearshoring of critical subassembly production. The cumulative effect of these changes influences product roadmaps-particularly for portable and handheld devices where trade-off decisions around probe complexity, digital processing, and embedded software have significant cost implications. Importantly, tariffs also accelerate strategic dialogues between manufacturers and payers about value-based procurement, total cost of ownership, and lifecycle support models, as both parties seek to preserve access to advanced imaging and therapeutic options without shifting unsustainable costs onto patients.

Detailed segmentation analysis revealing how product, component, portability, display, application, and end-user distinctions shape adoption and commercialization strategies

Segmentation drives clarity in product development, commercialization strategies, and clinical adoption. Based on Product, the market differentiates between Diagnostic Ultrasound Systems and Therapeutic Ultrasound Devices, where Diagnostic Ultrasound Systems are further divided into 2D Ultrasound, 3D & 4D Ultrasound, and Doppler Ultrasound, while Therapeutic Ultrasound Devices encompass Extracorporeal Shockwave Lithotripsy (ESWL), High-Intensity Focused Ultrasound (HIFU), and Technical Ultrasound. This product-level distinction highlights divergent engineering priorities: diagnostic systems emphasize image fidelity, workflow integration, and ergonomics, whereas therapeutic platforms prioritize energy delivery precision, targeting accuracy, and safety protocols.

Based on Component, the market is commonly considered across Probes and Workstations, making it clear that probe innovation-miniaturization, bandwidth, and multimodal capabilities-often drives perceived clinical value, while workstation software, processing power, and interoperability determine clinical efficiency and scalability. Based on Portability, the competitive landscape includes Cart Based and Portable & Handheld devices, with portability defining new access points for imaging services and creating distinct regulatory and reimbursement considerations.

Based on Display Type, distinctions between BW Ultrasound Devices and Color Ultrasound Devices continue to influence purchasing decisions in specialties where vascular flow visualization or detailed tissue characterization is critical. Based on Application, ultrasound use spans Interventional Procedures, Medical Diagnostics, Research & Development, and Veterinary sectors, with Interventional Procedures further broken into Anesthesia & Pain Management and Biopsies & Drainage, and Medical Diagnostics subdivided into Abdominal Imaging, Breast Imaging, Cardiology, Gastroenterology, Musculoskeletal Imaging, Obstetrics & Gynecology, Oncology, Ophthalmology, and Urology. Finally, based on End User, adoption and service models vary across Ambulatory Centers, Hospitals, Maternity Centers, and Research Laboratories, each with distinct procurement cycles, staffing profiles, and capital planning constraints.

This layered segmentation underscores why competitive strategies must be multi-dimensional: a single device can occupy multiple segments, and success requires aligning product specifications, distribution channels, and training programs to the nuanced needs of each clinical and commercial segment.

How regional differences across the Americas, Europe Middle East & Africa, and Asia-Pacific drive distinct adoption, regulatory, and commercialization strategies for ultrasound technologies

Regional dynamics are instrumental in shaping technology adoption, regulatory pathways, and commercial strategies. In the Americas, demand is driven by advanced hospital systems seeking high-performance diagnostic capabilities, growing adoption of point-of-care ultrasound, and heightened interest in therapeutic modalities that reduce procedural invasiveness. This region also exhibits proactive investment in digital health integration and reimbursement environments that increasingly recognize the value of imaging-driven care pathways.

In Europe, Middle East & Africa, heterogeneity defines market behavior: Western European markets typically prioritize clinical validation, interoperability, and long-term service partnerships, while emerging markets in the Middle East and Africa present opportunities for lower-cost portable solutions and public-private partnerships that expand access to imaging. Regulatory frameworks across the region vary substantially, necessitating tailored market entry strategies that reflect country-level approval requirements and procurement norms.

In Asia-Pacific, rapid infrastructure expansion, large patient volumes, and strong domestic manufacturing capabilities create both intense competition and significant opportunity. Several countries in this region are advancing local production, investing in AI research collaborations, and prioritizing telemedicine-enabled diagnostics to reach underserved populations. Across regions, differences in reimbursement, clinical practice patterns, and capital allocation cycles require companies to tailor product portfolios, pricing, and service models to regional realities while maintaining global consistency in quality and compliance.

Competitive behaviors and corporate strategies revealing why R&D depth, software ecosystems, and service models are the defining differentiators among leading ultrasound manufacturers

Leading companies in the ultrasound space are concentrating on several strategic levers simultaneously: sustained R&D investment in probe technology and image processing, expansion of software and cloud services, and commercial models that emphasize recurring revenue through service contracts and software subscriptions. Partnerships with academic centers and clinical networks are increasingly common as companies seek independent validation of AI algorithms, multi-center performance data, and real-world evidence to support regulatory approvals and payer engagement.

Competitive behavior is also characterized by targeted M&A and strategic alliances that fill capability gaps-acquiring niche AI startups, bolstering service networks, or integrating telehealth platforms to complement imaging offerings. In parallel, firms are diversifying manufacturing footprints and qualifying alternative suppliers to reduce exposure to geopolitical and tariff-related risks. Talent acquisition strategies prioritize clinicians, data scientists, and regulatory specialists who can accelerate translation of algorithmic capabilities into clinically validated workflows.

Service and training are emerging as differentiators: vendors that provide comprehensive education programs, remote proctoring, and robust post-sale support strengthen clinical adoption and reduce churn. Additionally, companies that commit to transparent clinical evidence and open software ecosystems create higher barriers to entry for new competitors and build trust with procurement committees focused on interoperability and lifecycle value. These collective behaviors suggest a market where innovation, strategic partnerships, and service excellence determine leadership.

Practical strategic priorities and executional steps that industry leaders should adopt to convert technological advances and policy shifts into sustainable competitive advantage

Industry leaders must act with clarity and speed to convert structural trends into sustainable advantage. First, prioritize investment in artificial intelligence and embedded software that demonstrably improves diagnostic accuracy and workflow efficiency, pairing algorithmic advances with rigorous clinical validation and transparent performance metrics to secure clinician trust and regulatory acceptance. Second, reengineer supply chains for flexibility: qualify secondary suppliers, expand regional manufacturing or assembly capabilities, and design product architectures that allow component substitution without heavy redesign.

Third, develop differentiated commercial models that combine hardware sales with subscription-based software, training packages, and outcome-linked service agreements. This will create recurring revenue and deepen customer relationships while aligning incentives around clinical outcomes. Fourth, accelerate the development of portable and handheld platforms targeted to point-of-care settings, ensuring these devices include seamless connectivity, telemedicine integration, and simplified user interfaces to broaden adoption beyond specialty imaging departments.

Fifth, invest in global regulatory expertise and payer engagement strategies to optimize reimbursement prospects for AI-enabled tools and therapeutic ultrasound applications. Sixth, build service and training programs that reduce time to proficiency and demonstrate return on investment for health systems. Finally, pursue strategic partnerships with clinical centers and technology providers to co-develop validated workflows, which will shorten adoption cycles and create defensible clinical differentiation. Acting on these priorities will position organizations to capture both short-term opportunities and long-term leadership in a rapidly evolving landscape.

A rigorous mixed-methods research approach combining secondary evidence, primary expert interviews, and triangulation to validate clinical, technical, and commercial conclusions

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure a balanced, evidence-based perspective. Secondary sources included peer-reviewed clinical literature, regulatory guidance documents, and public disclosures from device manufacturers to establish a factual baseline on technology capabilities, safety standards, and recent approvals. These were complemented by structured primary interviews with clinicians, biomedical engineers, procurement leaders, and industry executives to capture practical insights into adoption barriers, workflow impact, and procurement behavior.

Data triangulation was applied to reconcile differing viewpoints and ensure robust conclusions: clinical feedback was compared against regulatory trends and manufacturer roadmaps, while supply chain observations were validated through supplier and distributor interviews. Segmentation mapping involved cross-referencing product capabilities with clinical needs and end-user profiles to identify where innovations would have the greatest practical impact. Where possible, technical specifications and clinical validation studies were reviewed to corroborate claims about performance improvements.

Limitations of the methodology include reliance on available public data for certain proprietary technologies and potential variability in clinician perspectives across geographies and specialties. To mitigate these limitations, the research incorporated multiple stakeholder perspectives and prioritized evidence from clinical trials and peer-reviewed evaluations when assessing the efficacy and safety of emerging modalities.

Synthesis of strategic implications confirming why validated AI, supply chain agility, and integrated service models define future leadership in ultrasound

In conclusion, ultrasound is transitioning from a mature imaging modality to a dynamic platform at the intersection of diagnostics, therapy, and digital health. Technological advances such as AI, improved probe design, and portable form factors are expanding clinical use cases and creating new business models that bundle software, services, and outcome-oriented agreements. Tariff changes and geopolitical dynamics in 2025 have accelerated conversations about supply chain resilience, manufacturing footprints, and procurement criteria centered on risk mitigation and lifecycle value.

Segmentation nuances-spanning diagnostic versus therapeutic applications, component-level priorities, portability distinctions, display requirements, application-specific workflows, and end-user profiles-continue to drive strategic differentiation and product design choices. Regional variation in regulatory regimes, reimbursement, and clinical practice patterns further underscores the need for tailored go-to-market approaches. Competitive success will favor organizations that can pair technical excellence with credible clinical evidence, robust service models, and flexible commercial terms.

Ultimately, stakeholders that proactively invest in validated AI capabilities, supply chain agility, and integrated service offerings will be best positioned to capture the expanding role of ultrasound in modern care delivery. The insights in this report are intended to inform strategic planning, guide product development priorities, and support commercial decisions that accelerate adoption while safeguarding clinical quality and operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasound Market, by Product

  • 8.1. Diagnostic Ultrasound Systems
    • 8.1.1. 2D Ultrasound
    • 8.1.2. 3D & 4D Ultrasound
    • 8.1.3. Doppler Ultrasound
  • 8.2. Therapeutic Ultrasound Devices
    • 8.2.1. Extracorporeal Shockwave Lithotripsy (ESWL)
    • 8.2.2. High-Intensity Focused Ultrasound (HIFU)
    • 8.2.3. Technical Ultrasound

9. Ultrasound Market, by Component

  • 9.1. Probes
  • 9.2. Workstations

10. Ultrasound Market, by Portability

  • 10.1. Cart Based
  • 10.2. Portable & Handheld

11. Ultrasound Market, by Display Type

  • 11.1. BW Ultrasound Devices
  • 11.2. Color Ultrasound Devices

12. Ultrasound Market, by Application

  • 12.1. Interventional Procedures
    • 12.1.1. Anesthesia & Pain Management
    • 12.1.2. Biopsies & Drainage
  • 12.2. Medical Diagnostics
    • 12.2.1. Abdominal Imaging
    • 12.2.2. Breast Imaging
    • 12.2.3. Cardiology
    • 12.2.4. Gastroenterology
    • 12.2.5. Musculoskeletal Imaging
    • 12.2.6. Obstetrics & Gynecology
    • 12.2.7. Oncology
    • 12.2.8. Ophthalmology
    • 12.2.9. Urology
  • 12.3. Research & Development
  • 12.4. Veterinary

13. Ultrasound Market, by End User

  • 13.1. Ambulatory Centers
  • 13.2. Hospitals
  • 13.3. Maternity Centers
  • 13.4. Research Laboratories

14. Ultrasound Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Ultrasound Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Ultrasound Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Ultrasound Market

18. China Ultrasound Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. ALPINION Medical Systems Co., Ltd.
  • 19.6. Analogic Corporation
  • 19.7. B. Braun SE
  • 19.8. Bioevopeak Co., Ltd.
  • 19.9. Butterfly Network, Inc.
  • 19.10. Canon Medical Systems Corporation
  • 19.11. Cephasonics Ultrasound by White Eagle Sonic Technologies, Inc.
  • 19.12. CIVCO Medical Solutions
  • 19.13. CS Medical LLC
  • 19.14. Echonous Inc.
  • 19.15. Edan Instruments, Inc.
  • 19.16. Esaote SpA
  • 19.17. Fujifilm Holdings Corporation
  • 19.18. GE HealthCare Technologies Inc.
  • 19.19. Hitachi, Ltd.
  • 19.20. Hologic Inc.
  • 19.21. Konica Minolta Inc.
  • 19.22. Koninklijke Philips N.V
  • 19.23. Samsung Medison Co., Ltd.
  • 19.24. Shantou Institute of Ultrasonic Instruments Co., Ltd (SIUI)
  • 19.25. Shimadzu Corporation
  • 19.26. Siemens Healthcare Private Limited
  • 19.27. SonoScape Medical Corp.
  • 19.28. SternMed GmbH
  • 19.29. Stryker Corporation
  • 19.30. Telemed Medical Systems s.r.l
  • 19.31. WuHan Youkey Bio-Medical Electronics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ULTRASOUND MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ULTRASOUND MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ULTRASOUND MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ULTRASOUND MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ULTRASOUND MARKET SIZE, BY 3D & 4D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ULTRASOUND MARKET SIZE, BY 3D & 4D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ULTRASOUND MARKET SIZE, BY 3D & 4D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASOUND MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ULTRASOUND MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ULTRASOUND MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRASOUND MARKET SIZE, BY EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRASOUND MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRASOUND MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASOUND MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND MARKET SIZE, BY TECHNICAL ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND MARKET SIZE, BY TECHNICAL ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND MARKET SIZE, BY TECHNICAL ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND MARKET SIZE, BY PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASOUND MARKET SIZE, BY PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASOUND MARKET SIZE, BY PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASOUND MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASOUND MARKET SIZE, BY WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ULTRASOUND MARKET SIZE, BY WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRASOUND MARKET SIZE, BY CART BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRASOUND MARKET SIZE, BY CART BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASOUND MARKET SIZE, BY CART BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABLE & HANDHELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABLE & HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASOUND MARKET SIZE, BY PORTABLE & HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND MARKET SIZE, BY BW ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND MARKET SIZE, BY BW ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASOUND MARKET SIZE, BY BW ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ULTRASOUND MARKET SIZE, BY COLOR ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ULTRASOUND MARKET SIZE, BY COLOR ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ULTRASOUND MARKET SIZE, BY COLOR ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ULTRASOUND MARKET SIZE, BY ANESTHESIA & PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ULTRASOUND MARKET SIZE, BY ANESTHESIA & PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ULTRASOUND MARKET SIZE, BY ANESTHESIA & PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ULTRASOUND MARKET SIZE, BY BIOPSIES & DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ULTRASOUND MARKET SIZE, BY BIOPSIES & DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ULTRASOUND MARKET SIZE, BY BIOPSIES & DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ULTRASOUND MARKET SIZE, BY ABDOMINAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ULTRASOUND MARKET SIZE, BY ABDOMINAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ULTRASOUND MARKET SIZE, BY ABDOMINAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ULTRASOUND MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ULTRASOUND MARKET SIZE, BY BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ULTRASOUND MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ULTRASOUND MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ULTRASOUND MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ULTRASOUND MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ULTRASOUND MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ULTRASOUND MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ULTRASOUND MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ULTRASOUND MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ULTRASOUND MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ULTRASOUND MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ULTRASOUND MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ULTRASOUND MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ULTRASOUND MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ULTRASOUND MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ULTRASOUND MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ULTRASOUND MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ULTRASOUND MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ULTRASOUND MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ULTRASOUND MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ULTRASOUND MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ULTRASOUND MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ULTRASOUND MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ULTRASOUND MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ULTRASOUND MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ULTRASOUND MARKET SIZE, BY MATERNITY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ULTRASOUND MARKET SIZE, BY MATERNITY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ULTRASOUND MARKET SIZE, BY MATERNITY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ULTRASOUND MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 214. GCC ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. G7 ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 258. NATO ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. NATO ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 261. NATO ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA ULTRASOUND MARKET SIZE, BY DIAGNOSTIC ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA ULTRASOUND MARKET SIZE, BY THERAPEUTIC ULTRASOUND DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA ULTRASOUND MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA ULTRASOUND MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA ULTRASOUND MARKET SIZE, BY DISPLAY TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA ULTRASOUND MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA ULTRASOUND MARKET SIZE, BY MEDICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)